K23 CA124802/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2009	3
2010	5
2011	1
2012	4
2013	3
2014	3
2015	2
2016	1
2024	0

1

Cancer pharmacogenomics: strategies and challenges.

Wheeler HE, Maitland ML, Dolan ME, Cox NJ, Ratain MJ. Wheeler HE, et al. Nat Rev Genet. 2013 Jan;14(1):23-34. doi: 10.1038/nrg3352. Epub 2012 Nov 27. Nat Rev Genet. 2013. PMID: 23183705 Free PMC article. Review.

2

Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors.

Snider KL, Maitland ML. Snider KL, et al. Target Oncol. 2009 Apr;4(2):67-76. doi: 10.1007/s11523-009-0106-0. Epub 2009 Apr 17. Target Oncol. 2009. PMID: 19373440 Free PMC article. Review.

3

Analysis of the yield of phase II combination therapy trials in medical oncology.

Maitland ML, Hudoba C, Snider KL, Ratain MJ. Maitland ML, et al. Clin Cancer Res. 2010 Nov 1;16(21):5296-302. doi: 10.1158/1078-0432.CCR-10-0669. Epub 2010 Sep 13. Clin Cancer Res. 2010. PMID: 20837695 Free PMC article. Review.

4

Vascular endothelial growth factor pathway.

Maitland ML, Lou XJ, Ramirez J, Desai AA, Berlin DS, McLeod HL, Weichselbaum RR, Ratain MJ, Altman RB, Klein TE. Maitland ML, et al. Pharmacogenet Genomics. 2010 May;20(5):346-9. doi: 10.1097/FPC.0b013e3283364ed7. Pharmacogenet Genomics. 2010. PMID: 20124951 Free PMC article. Review. No abstract available.

5

Models of excellence: improving oncology drug development.

Sharma MR, Maitland ML, Ratain MJ. Sharma MR, et al. Clin Pharmacol Ther. 2012 Nov;92(5):548-50. doi: 10.1038/clpt.2012.99. Clin Pharmacol Ther. 2012. PMID: 23085878 Free PMC article.

6

Clinical trials in the era of personalized oncology.

Maitland ML, Schilsky RL. Maitland ML, et al. CA Cancer J Clin. 2011 Nov-Dec;61(6):365-81. doi: 10.3322/caac.20135. Epub 2011 Oct 27. CA Cancer J Clin. 2011. PMID: 22034206 Free PMC article.

7

Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.

Bhatta SS, Wroblewski KE, Agarwal KL, Sit L, Cohen EE, Seiwert TY, Karrison T, Bakris GL, Ratain MJ, Vokes EE, Maitland ML. Bhatta SS, et al. Oncologist. 2013;18(8):965-70. doi: 10.1634/theoncologist.2013-0006. Epub 2013 Jul 30. Oncologist. 2013. PMID: 23900000 Free PMC article.

8

Resampling phase III data to assess phase II trial designs and endpoints.

Sharma MR, Karrison TG, Jin Y, Bies RR, Maitland ML, Stadler WM, Ratain MJ. Sharma MR, et al. Clin Cancer Res. 2012 Apr 15;18(8):2309-15. doi: 10.1158/1078-0432.CCR-11-1815. Epub 2012 Jan 27. Clin Cancer Res. 2012. PMID: 22287601 Free PMC article.

9

Technical considerations in the development of circulating peptides as pharmacodynamic biomarkers for angiogenesis inhibitors.

Thomeas V, Chow S, Gutierrez JO, Karovic S, Wroblewski K, Kistner-Griffin E, Karrison TG, Maitland ML. Thomeas V, et al. J Clin Pharmacol. 2014 Jun;54(6):682-7. doi: 10.1002/jcph.254. Epub 2014 Jan 17. J Clin Pharmacol. 2014. PMID: 24374901 Free PMC article. Clinical Trial.

10

Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling.

Li CH, Bies RR, Wang Y, Sharma MR, Karovic S, Werk L, Edelman MJ, Miller AA, Vokes EE, Oto A, Ratain MJ, Schwartz LH, Maitland ML. Li CH, et al. Clin Transl Sci. 2016 Feb;9(1):43-50. doi: 10.1111/cts.12384. Epub 2016 Jan 21. Clin Transl Sci. 2016. PMID: 26790562 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year